The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, September 05, 2018
Fibrocell Science announced that the FDA has granted Fast Track Designation to FCX-013, the company’s clinical stage candidate for the treatment of ...
read more
Wednesday, September 05, 2018
It is CGPA's understanding that there are many US proposals on the table that would require changes to Canadian law and delay competition from generic...
read more
Thursday, August 30, 2018
Emergent BioSolutions has entered into an agreement to acquire Adapt Pharma and its flagship product Narcan Nasal Spray for the emergency treatment of...
read more
TARIS announced positive preliminary safety and efficacy data from its clinical study of TAR-302 for the treatment of patients with idiopathic ...
read more
Thursday, August 23, 2018
The FDA took additional action to mitigate shortages of EpiPen auto-injector by extending the expiration date of specific lots of 0.3 milligram ...
read more
The FDA approved the first generic version of EpiPen and EpiPen Jr auto-injector for the emergency treatment of allergic reactions in adults and ...
read more
Thursday, August 02, 2018
MilliporeSigma and InnoCore Pharmaceuticals have entered into a global cooperation agreement to provide InnoCore’s proprietary SynBiosys biodegradable...
read more
The FDA approved Azedra injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal ...
read more
BioPharmX has received Institutional Review Board approval for its phase 2 study of BPX-04 for the treatment of papulopustular rosacea.
read more
Sanofi Pasteur has shipped the first of its nearly 70 million flu vaccine doses to health care providers for the upcoming flu season.
read more
Durect announced that Indivior has reported the FDA has approved the NDA for Perseris (risperidone), which was formerly known as RBP-7000.
read more
Bayer has decided to voluntarily discontinue sales and distribution of the Essure System for Permanent Birth Control in the United States after ...
read more
BioArctic AB announced the company has received approval by Fimea and Valvira, as well as the local ethics committee for inclusion of Finnish patients...
read more
The U.S. Food and Drug Administration today expanded the approval of the MiniMed 670G hybrid closed looped system, a diabetes management device that ...
read more
Amphastar Pharmaceuticals announced that the U.S. Food and Drug Administration (“FDA”) has granted approval of its abbreviated new drug application (“...
read more